Literature DB >> 33326734

Spectrum of Fibrotic Lung Diseases. Reply.

Marlies Wijsenbeek1, Vincent Cottin2.   

Abstract

Entities:  

Year:  2020        PMID： 33326734     DOI： 10.1056/NEJMc2031135

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Targeting fatty acid metabolism for fibrotic disorders.

Authors:  Seonghwan Hwang; Ki Wung Chung
Journal:  Arch Pharm Res       Date:  2021-10-18       Impact factor: 4.946

2.  Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.

Authors:  Marlies Wijsenbeek; Maria Molina-Molina; Olivier Chassany; John Fox; Liam Galvin; Klaus Geissler; Katherine M Hammitt; Michael Kreuter; Teng Moua; Emily C O'Brien; Ashley F Slagle; Anna Krasnow; Matthew Reaney; Michael Baldwin; Natalia Male; Klaus B Rohr; Jeff Swigris; Katerina Antoniou
Journal:  ERJ Open Res       Date:  2022-05-03

Review 3.  Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.

Authors:  Naoki Inui; Satoshi Sakai; Masatoshi Kitagawa
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.